In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
VANCOUVER,BC / ACCESS Newswire / September 29, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience company specializing in innovative drug delivery ...
The patent comes months after Immunic Therapeutics announced CALLIPER study results, which tested vidofludimus calcium in progressive MS.
J. Tyler Davidson of the Department of Forensic Science at Sam Houston State University (Huntsville, Texas) used liquid ...
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple SclerosisAcross non-active progressive MS (primary progressive and secondary ...
Multiple sclerosis (MS) is a chronic autoimmune and neurodegenerative disease of the central nervous system (CNS), affecting ...
In the first part of this Q&A, Kathy Oubre, MS, discusses how likely it is that the most favored nation executive order will lead to price reductions in prescription drugs. In the first part of this Q ...
ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple ...
As the Democratic Republic of Congo faces its 16th Ebola outbreak, aid cuts mean support for its response is dwindling, ...
GeneDx CEO Katherine Stueland explains how her company screens babies’ DNA for mutations that cause thousands of treatable ...
PsyPost on MSN
Cannabis compounds have distinct effects on brain connectivity and blood flow, study finds
Scientists have discovered that THC and CBD push the brain in opposite directions. A neuroimaging study in rats shows that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback